Verified employee & interview reviews

Advent International India Reviews

Mumbai, Maharashtra

4.3/ 5

3 reviews

Advent International India is the regional arm of Advent International Corporation, an American private equity firm founded in 1984 by Peter Brooke. Headquartered globally in Boston, Massachusetts, Advent is one of the largest and most experienced global private equity investors. The firm established its presence in India to capitalize on the country's high-growth economy, operating out of its office in Mumbai (specifically located at the One World Center in Lower Parel). In India and across the globe, Advent leverages deep sub-sector specialization and local market knowledge to identify innovative businesses and drive long-term value creation. The firm focuses on five core sectors: business and financial services, healthcare, retail and consumer, industrials, and technology. Advent’s investment strategy in India spans complex corporate carve-outs, public-to-private deals, and growth equity investments, partnering with large corporations, family-owned businesses, and entrepreneurs. Advent's Indian portfolio features prominent investments across multiple sectors. In financial services, the firm has backed companies like YES Bank, Aditya Birla Housing Finance, KreditBee, and Svatantra, a non-bank microfinance institution. In the technology and analytics space, it has invested in platforms such as Tredence, Tekion, and CarDekho. The firm is also highly active in the industrial and consumer sectors, having notable engagements with rigid plastic packaging provider Manjushree Technopack and food manufacturer Iscon Balaji Foods. One of Advent's most notable success stories in the Indian market is its investment in Bharat Serums and Vaccines (BSV). Advent acquired the business, overhauled its operations, upgraded its governance structure, and focused research and development heavily on women's health and fertility products. Under Advent's ownership, BSV transformed into a leading domestic and international specialist provider before ultimately being sold to a strategic buyer. Furthermore, Advent has expanded its pharmaceutical footprint in India through significant acquisitions, including taking a 50.1% controlling stake in Suven Pharmaceuticals. Globally, Advent manages approximately $91 billion to $100 billion in assets under management. The firm operates out of 14 offices across 11 countries, employing hundreds of investment professionals. Its global investment vehicles, such as the GPE X fund which reached $25 billion in commitments, provide the capital necessary to support large-scale buyouts. Advent employs a patient, hands-on partnership model, working closely with the management teams of its portfolio companies, alongside its internal Portfolio Support Group and Operating Partners, to implement sustainable, long-term growth strategies.